China Pharma Holdings Inc. announced that its wholly owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd, has entered into a Technology Transfer Agreement with Juan Zhang for the acquisition of an invention patent related to Ipragliflozin tablets. As part of the agreement, the company will issue 7,000,000 restricted shares of its common stock, valued at $1.40 per share, as payment for the $9.8 million transfer price. The shares will be issued as an unregistered sale and offered in reliance on Regulation S, exempting them from registration under the Securities Act.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Pharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-125299), on December 23, 2025, and is solely responsible for the information contained therein.